BayCare Health Systems & Prolacta Bioscience Set Pace for Premature Infant 100% Breastmilk Diet

Chance & Sienna’s Story

Partnership with Prolacta Bioscience (PilmerPR client) Ensures a Safe, Standardized, and Steady Supply of Pasteurized Donor Milk to Meet Feeding Needs of Premature Infants throughout BayCare Health System

CLEARWATER, Fla., July 11, 2013 /PRNewswire-USNewswire/ — BayCare Health System has announced a partnership with Prolacta Bioscience to ensure a safe, standardized, and steady supply of pasteurized donor breast milk to meet the feeding requirements of their hospitalized premature infant population. Under the partnership, Prolacta will manage the breast milk donor qualification process by conducting health screenings, blood testing, and the milk collection process for BayCare Health System’s newly established BayCare Donor Milk Program. Prolacta also will conduct safety and quality testing before pasteurizing the human milk products for in-hospital use…

FULL RELEASE

January of 2009, at a little over 27 weeks of gestation, Chance and Sienna had surprising New Year’s plans. With three months left before their due date, they decided to make their grand entrance into the world while mom and dad were vacationing just outside of Sarasota, FL. Chance made his entry weighing two pounds, three ounces, and Sienna arrived weighing one pound, 15 ounces.

About the Author:

As founder of PilmerPR, John Pilmer, APR serves as a PR and marketing communications advisor for both emerging and established companies. He offers customers more than 20 years of results-driven business PR and marketing experience. John and the firm have provided PR consultation and campaigns for clients such as Mozy, Novell, AdvancedMD, Certiport, NextPage, ElectraTherm, Altiris, Avamar, EmergeCore Networks, FSLogic, INVISUS, 10x Marketing, MWI, Project Insight, REIC, Seastone, US Synthetic and Funding Universe (now Lendio), among others.
  Related Posts

Add a Comment